SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-18-001641
Filing Date
2018-03-07
Accepted
2018-03-07 16:46:11
Documents
82
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K imgn-20171231x10k.htm 10-K 3643710
2 EX-10.30 imgn-20171231ex103054e89.htm EX-10.30 138820
3 EX-21 imgn-20171231ex210cf7eb6.htm EX-21 7000
4 EX-23 imgn-20171231xex23.htm EX-23 3713
5 EX-31.1 imgn-20171231ex311d0bd59.htm EX-31.1 20987
6 EX-31.2 imgn-20171231ex31281bffb.htm EX-31.2 17684
7 EX-32 imgn-20171231xex32.htm EX-32 15062
  Complete submission text file 0001558370-18-001641.txt   14853068

Data Files

Seq Description Document Type Size
8 EX-101.INS imgn-20171231.xml EX-101.INS 3619641
9 EX-101.SCH imgn-20171231.xsd EX-101.SCH 72340
10 EX-101.CAL imgn-20171231_cal.xml EX-101.CAL 64887
11 EX-101.DEF imgn-20171231_def.xml EX-101.DEF 340542
12 EX-101.LAB imgn-20171231_lab.xml EX-101.LAB 661983
13 EX-101.PRE imgn-20171231_pre.xml EX-101.PRE 594335
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-17999 | Film No.: 18673865
SIC: 2834 Pharmaceutical Preparations